Heterogeneous Longitudinal Antibody Responses to Covid-19 mRNA Vaccination.

Suzanne M de la MonteChristine LongNicole SzczepanskiChristopher GriffinAmanda FitzgeraldKimberle Chapin

Published in: Clinical pathology (Thousand Oaks, Ventura County, Calif.) (2021)

Host responses to SARS-CoV-2-Spike mRNA vaccines vary in magnitude, duration and occurrence. This study raises concern about the lack of vaccine protection in as many as 8% of otherwise normal people, and the need for open dialog about future re-boosting requirements to ensure long-lasting immunity via mRNA vaccination versus natural infection.

Keyphrases

sars cov
binding protein
coronavirus disease
respiratory syndrome coronavirus
risk assessment
minimally invasive
cross sectional